相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of TrkB signaling
Atsuhiro Fujita et al.
PSYCHOPHARMACOLOGY (2020)
Ablation of the tail of the ventral tegmental area compensates symptoms in an experimental model of Parkinson's disease
Fanny Faivre et al.
NEUROBIOLOGY OF DISEASE (2020)
Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia
Mitchell J. Bartlett et al.
EXPERIMENTAL NEUROLOGY (2020)
Anxiety-like behavior induced by 6-OHDA animal model of Parkinson's disease may be related to a dysregulation of neurotransmitter systems in brain areas related to anxiety
Jeane Cristina F. Vieira et al.
BEHAVIOURAL BRAIN RESEARCH (2019)
Role of Serotonin and Noradrenaline in the Rapid Antidepressant Action of Ketamine
Xavier Lopez-Gil et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Differential impairment of short working and spatial memories in a rat model of progressive Parkinson's disease onset: A focus on the prodromal stage
Ahmed Draoui et al.
BRAIN RESEARCH BULLETIN (2019)
The hidden side of Parkinson's disease: Studying pain, anxiety and depression in animal models
Fanny Faivre et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars cornpacta in rats: Therapeutic implications for Parkinson's disease
Debora Dalla Vecchia et al.
BEHAVIOURAL BRAIN RESEARCH (2018)
Effect of striatal dopamine depletion on cognition in de novo Parkinson's disease
Seok Jong Chung et al.
PARKINSONISM & RELATED DISORDERS (2018)
Attenuation of Antidepressant Effects of Ketamine by Opioid Receptor Antagonism
Nolan R. Williams et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Targeting the norepinephrinergic system in Parkinson's disease and related disorders: The locus coeruleus story
Yannick Vermeiren et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
Neuron-protective effect of subanesthestic-dosage ketamine on mice of Parkinson's disease
Jun-Chao Fan et al.
ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE (2017)
Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area
D. Dardou et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Ceftriaxone reverses deficits of behavior and neurogenesis in an MPTP-induced rat model of Parkinson's disease dementia
Ming-Hong Hsieh et al.
BRAIN RESEARCH BULLETIN (2017)
Management of Depression in Parkinson's Disease: A Systematic Review
Sergio E. Starkstein et al.
MOVEMENT DISORDERS CLINICAL PRACTICE (2017)
Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression
Mariusz Papp et al.
BEHAVIOURAL PHARMACOLOGY (2017)
Lack of effect of chronic ketamine administration on depression-like behavior and frontal cortex autophagy in female and male ICR mice
N. Z. Kara et al.
BEHAVIOURAL BRAIN RESEARCH (2017)
Duality of Antidepressants and Neuroprotectants
Yousef Tizabi
NEUROTOXICITY RESEARCH (2016)
Ketamine as a Prophylactic Against Stress-Induced Depressive-like Behavior
Rebecca A. Brachman et al.
BIOLOGICAL PSYCHIATRY (2016)
A promising therapeutic potential of cerebrolysin in 6-OHDA rat model of Parkinson's disease
Neveen A. Noor et al.
LIFE SCIENCES (2016)
NMDAR inhibition-independent antidepressant actions of ketamine metabolites
Panos Zanos et al.
NATURE (2016)
Long-term effect of sub-anesthetic ketamine in reducing L-DOPA-induced dyskinesias in a preclinical model
Mitchell J. Bartlett et al.
NEUROSCIENCE LETTERS (2016)
Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review
Kristian Gaarn du Jardin et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2016)
Differential interaction with the serotonin system by S-ketamine, vortioxetine, and fluoxetine in a genetic rat model of depression
Kristian Gaarn du Jardin et al.
PSYCHOPHARMACOLOGY (2016)
Role of hippocampal p11 in the sustained antidepressant effect of ketamine in the chronic unpredictable mild stress model
H-L Sun et al.
TRANSLATIONAL PSYCHIATRY (2016)
Case Reports Showing a Long-Term Effect of Subanesthetic Ketamine Infusion in Reducing L-DOPA-Induced Dyskinesias
Scott J. Sherman et al.
CASE REPORTS IN NEUROLOGY (2016)
Non-motor signs in Parkinson's disease: a review
Renato P. Munhoz et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2015)
Effects of Hypericum perforatum on turning behavior in an animal model of Parkinson's disease
Debora Dalla Vecchia et al.
BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Apathy and noradrenaline: silent partners to mild cognitive impairment in Parkinson's disease?
Leyla Loued-Khenissi et al.
CURRENT OPINION IN NEUROLOGY (2015)
THE NONSTEROIDAL ANTIINFLAMMATORY DRUG PIROXICAM REVERSES THE ONSET OF DEPRESSIVE-LIKE BEHAVIOR IN 6-OHDA ANIMAL MODEL OF PARKINSON'S DISEASE
R. M. Santiago et al.
NEUROSCIENCE (2015)
Neurotoxin Mechanisms and Processes Relevant to Parkinson's Disease: An Update
Juan Segura-Aguilar et al.
NEUROTOXICITY RESEARCH (2015)
Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway
Julianne D. Jett et al.
PSYCHOPHARMACOLOGY (2015)
Nitric oxide involvement in the antidepressant-like effect of ketamine in the Flinders sensitive line rat model of depression
Nico Liebenberg et al.
ACTA NEUROPSYCHIATRICA (2015)
BDNF Release Is Required for the Behavioral Actions of Ketamine
Ashley E. Lepack et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2015)
Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
Chandana Buddhala et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2015)
SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats
Lin Chen et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action
Marie Naughton et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease
G. Drui et al.
MOLECULAR PSYCHIATRY (2014)
Glutamate-Based Antidepressants: Preclinical Psychopharmacology
Andrzej Pilc et al.
BIOLOGICAL PSYCHIATRY (2013)
Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia
Kelly Del Tredici et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Understanding cognitive deficits in Parkinson's disease: lessons from preclinical animal models
Nicola Solari et al.
LEARNING & MEMORY (2013)
Animal Models of Parkinson's Disease: Limits and Relevance to Neuroprotection Studies
Erwan Bezard et al.
MOVEMENT DISORDERS (2013)
Ketamine elicits sustained antidepressant-like activity via a serotonin-dependent mechanism
Valentina Gigliucci et al.
PSYCHOPHARMACOLOGY (2013)
Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants
Caroline A. Browne et al.
FRONTIERS IN PHARMACOLOGY (2013)
Effects of MK-801 on recognition and neurodegeneration in an MPTP-induced Parkinson's rat model
Ming-Hong Hsieh et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease
Adalberto A. Castro et al.
BEHAVIOURAL BRAIN RESEARCH (2012)
Ketamine for Depression: Where Do We Go from Here?
Marije Aan Het Rot et al.
BIOLOGICAL PSYCHIATRY (2012)
Cognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?
Hanna S. Lindgren et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment
Per Svenningsson et al.
LANCET NEUROLOGY (2012)
Using the rat forced swim test to assess antidepressant-like activity in rodents
David A. Slattery et al.
NATURE PROTOCOLS (2012)
Depression in Parkinson disease-epidemiology, mechanisms and management
Dag Aarsland et al.
NATURE REVIEWS NEUROLOGY (2012)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
NEUROTOXIN-BASED MODELS OF PARKINSON'S DISEASE
J. Bove et al.
NEUROSCIENCE (2012)
Studies of Depression-Related States in Animal Models of Parkinsonism
Nicoletta Schintu et al.
JOURNAL OF PARKINSONS DISEASE (2012)
Neonatal exposure to constant light prevents anhedonia-like behavior induced by constant light exposure in adulthood
Bruno J. Martynhak et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Effects of D-cycloserine on MPTP-induced behavioral and neurological changes: Potential for treatment of Parkinson's disease dementia
Ying-Jui Ho et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Potential mechanisms underlying anxiety and depression in Parkinson's disease: Consequences of L-DOPA treatment
Karen L. Eskow Jaunarajs et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2011)
Noradrenaline and Parkinson's disease
Claire Delaville et al.
FRONTIERS IN SYSTEMS NEUROSCIENCE (2011)
Involvement of NMDA receptors in both MPTP-induced neuroinflammation and deficits in episodic-like memory in Wistar rats
An-Li Wang et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Intranigral LPS Administration Produces Dopamine, Glutathione but not Behavioral Impairment in Comparison to MPTP and 6-OHDA Neurotoxin Models of Parkinson's Disease
Deborah Ariza et al.
NEUROCHEMICAL RESEARCH (2010)
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson's Disease
Rui D. S. Prediger et al.
NEUROTOXICITY RESEARCH (2010)
A timeline for Parkinson's disease
Christopher H. Hawkes et al.
PARKINSONISM & RELATED DISORDERS (2010)
Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine
Ronise M. Santiago et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
Learning processing in the basal ganglia: A mosaic of broken mirrors
Claudio Da Cunha et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
EMOTIONAL, COGNITIVE AND NEUROCHEMICAL ALTERATIONS IN A PREMOTOR STAGE MODEL OF PARKINSON'S DISEASE
M. T. Tadaiesky et al.
NEUROSCIENCE (2008)
Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rat hippocampus
Leda S. B. Garcia et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2008)
Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats
Christine Winter et al.
BEHAVIOURAL BRAIN RESEARCH (2007)
Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model
Fabio Blandini et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test
Fernando T. Consoni et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Different parkinsonism models produce a time-dependent induction of COX-2 in the substantia nigra of rats
Marcelo de Meira Santos Lima et al.
BRAIN RESEARCH (2006)
Non-motor symptoms of Parkinson's disease: diagnosis and management
KR Chaudhuri et al.
LANCET NEUROLOGY (2006)
Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: Histological, neurochemical, motor and memory alterations
MM Ferro et al.
JOURNAL OF NEUROSCIENCE METHODS (2005)
Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL/6 mice
A Mori et al.
NEUROSCIENCE RESEARCH (2005)
Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test
JF Cryan et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Is the unilateral lesion of the left substantia nigra pars compacta sufficient to induce working memory impairment in rats?
MI Bellissimo et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2004)
NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats
JE Kelsey et al.
PSYCHOPHARMACOLOGY (2004)
Facilitation of short-term social memory by ethanol in rats is mediated by dopaminergic receptors
RDS Prediger et al.
BEHAVIOURAL BRAIN RESEARCH (2004)
Evidence for the substantia nigra pars compacta as an essential component of a memory system independent of the hippocampal memory system
C Da Cunha et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2003)
Modeling Parkinsn's disease in rats: An evaluation of 6-OHDA lesions of the nigrostriatal pathway
R Deumens et al.
EXPERIMENTAL NEUROLOGY (2002)
Memory disruption in rats with nigral lesions induced by MPTP: a model for early Parkinson's disease amnesia
C Da Cunha et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Caffeine reverses the memory disruption induced by intra-nigral MPTP-injection in rats
MS Gevaerd et al.
BRAIN RESEARCH BULLETIN (2001)
Functional changes of the basal ganglia circuitry in Parkinson's disease
F Blandini et al.
PROGRESS IN NEUROBIOLOGY (2000)
What contributes to quality of life in patients with Parkinson's disease?
A Schrag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2000)
分享论文
